Our study also observed a lower level of CCL5 in the serum of patients with cirrhosis, and CCL5 expression in serum of patients increased significantly in the development from cirrhosis to hepatocellular carcinoma. This evidence concerns the gene CCL5 and hepatocellular carcinoma.